Tagged: Valeant Pharmaceuticals

Valeant Pharmaceuticals (Now Bausch Health) and Three Former Executives Settle SEC Cases

Valeant Pharmaceuticals (Now Bausch Health) and Three Former Executives Settle SEC Cases

Bausch Health agreed to pay the SEC $45 million to settle Valeant Pharmaceuticals (former name) accounting fraud schemes.  Three former executives, former CEO Michael Pearson, CFO Howard Schiller and Controller Tanya Carro also settled with SEC.  Pearson agreed to pay a civil penalty of $250,000 and repaid Bausch $450,000 in compensation; Schiller agreed to pay a civil penalty of $100,000 and repaid Bausch $110,000 in...

Two Executives Charged in Valeant Pharmaceuticals Criminal Investigation

Two Executives Charged in Valeant Pharmaceuticals Criminal Investigation

Two executives were charged last week with criminal violations in the Southern District of New York relating to Valeant Pharmaceuticals activities. These charges are the first of more to come in an ongoing investigation focusing on Valeant’s corporate demise from a high-flying pharmaceutical company. I have written before about Valeant’s rotten culture, slavish devotion to quarterly performance, and short-sighted management culture that ultimately bred a...

The Demise of Valeant Pharmaceuticals: A Case Study in Rotten Culture and Business Ethics

The Demise of Valeant Pharmaceuticals: A Case Study in Rotten Culture and Business Ethics

Showing my age again, Woody Allen’s Take the Money and Run included a hilarious scene when Woody’s parents wearing Groucho Marx glasses talk about their criminal son (Woody/Virgil Starkwell), his dad exclaimed “He’s rotten, he is a gangster.”  See clip here. Well, the story of Valeant Pharmaceuticals is a familiar one of corporate greed and misconduct, based on a “rotten” tone at the top and...